Clinical Trials Logo
  1. Home
  2. HIV Infections
  3. NCT05123547
  4. Details
NCT05123547 Clinical Trial

DENTAL CARE OF PATIENTS LIVING WITH HIV

HIV Infections Clinical Trial

— DENTA-VIH  

Official title:
DENTAL CARE OF PATIENTS LIVING WITH HIV, OR COINFECTED HIV / HBV OR HIV / HCV, FOLLOWED IN THE INFECTIOUS DISEASES DEPARTMENT OF CHU CLERMONT-FERRAND

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05123547
Other study ID # RNI 2021 JACOMET 3
Secondary ID 2021-A01831-40
Status Completed
Phase
First received
Last updated
Start date October 21, 2021
Est. completion date April 21, 2022

Study information
Verified date May 2022
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is perform to identify oral diseases of people living with HIV (PLWHIV) or co-infected with HBV or HCV.

Description:

In the purpose of identifying oral diseases of people living with HIV (PLWHIV) or co-infected with HBV or HCV, we would recruit from 15 10 2021 to 15 04 2022 affiliated to social security scheme PLWHIV adults followed-up in the infectious diseases department of Clermont-Ferrand university hospital who accept participate in order to propose dental individual clinical exams. Anonymous socio-demograpic, medical and dental data will be reported in Redcap. Primary outcomes are the number and type of pathologies identified linked to HIV or not. Statistical analysed will be performed with Stata software. The population will be described by associated numbers and percentages for the categorical variables and by the mean ± standard deviation or median [interquartile interval] for the quantitative variables, with respect to their statistical distribution.

Recruitment information / eligibility
Status Completed
Enrollment 112
Est. completion date April 21, 2022
Est. primary completion date April 21, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patient infected with HIV or co-infected with HIV / HBV or HIV / HCV followed in the Infectious Diseases department of Clermont-Ferrand University Hospital and affiliated to a social security scheme. Exclusion Criteria: - Minor patient - Adult patient unable to express his non-opposition to participating in the study or patient who refuses to participate in the study.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France CHU clermont-ferrand Clermont-Ferrand

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary description of oral disease linked to HIV or not. percentage of patients with oral disease linked to HIV and percentage of patients with oral disease not linked to HIV During the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrand
Secondary Study the factors associated with the presence of oral pathologies linked to HIV. bivariate and multivariate analysis of demographic, immunovirologic factors and comorbidities associated to oral diseases linked to HIV During the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrand
Secondary Study the factors associated with the presence of oral pathologies unrelated to HIV. bivariate and multivariate analysis of demographic, immunovirologic factors and comorbidities associated with the presence of oral pathologies unrelated to HIV During the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrand
Secondary Compare the prevalence of oral pathologies linked or not to HIV with that found in a previous study carried out in 2003. comparison of prevalence of oral diseases in 2021 and those in 2003 in CHU Clermont Ferrand During the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrand
Secondary List the course of dental care of these people during the last 3 years. % refusal care, % lost of dental follow-up During the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrand
See also
  Status Clinical Trial Phase
Completed NCT05454514 - Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS N/A
Completed NCT03760458 - The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age Phase 1/Phase 2
Completed NCT03141918 - Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS N/A
Completed NCT03067285 - A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study Phase 4
Recruiting NCT04579146 - Coronary Artery Disease (CAD) in Patients HIV-infected
Completed NCT06212531 - Papuan Indigenous Model of Male Circumcision N/A
Active, not recruiting NCT03256422 - Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients Phase 3
Completed NCT03256435 - Retention in PrEP Care for African American MSM in Mississippi N/A
Completed NCT00517803 - Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies N/A
Active, not recruiting NCT03572335 - Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
Completed NCT04165200 - Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV N/A
Recruiting NCT03854630 - Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection Phase 4
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT02234882 - Study on Pharmacokinetics Phase 1
Completed NCT01618305 - Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission Phase 4
Recruiting NCT05043129 - Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
Not yet recruiting NCT05536466 - The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine N/A
Recruiting NCT04985760 - Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy Phase 1
Completed NCT05916989 - Stimulant Use and Methylation in HIV
Terminated NCT02116660 - Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284) Phase 2